Prot #D6060C00002: A Phase 1 Multicenter, Open-label, Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Antitumor Activity of MEDI0562 in Combination with Immune Therapeutic Agents in Adult Subjects with Advanced Solid

Project: Research project

Project Details

StatusFinished
Effective start/end date6/30/16 → 6/30/19

Funding

  • ICON Clinical Research, LLC (Prot #D6060C00002 // Prot #D6060C00002)
  • MedImmune, LLC (Prot #D6060C00002 // Prot #D6060C00002)